(chemotherapy, radioisotopes, immunotherapy, gene therapy, boron neutron capture therapy, photothermal therapy, and photodynamic therapy), and the delivery systems for theranostics (lipid- and polymer-based nanotheranostics, bio-inspired protein-based nanotheranostics, bioimaging hybrid nanocrystals, nano-...
Cuproptosis provides evidence that increasing the amount of Cu in tumor tissue kills tumor cells. In addition, cuproptosis has broadened the field of cancer therapy. 3.1. Mechanism of cuproptosis Cuproptosis is a novel mechanism different from the currently known cell death mechanisms, which is ...
BNCT therapydose distribution monitoringPET tomographyThis short review summarizes the issue of boron distribution monitoring in boron neutron capture therapy (BNCT), which remains a serious drawback of this powerful oncological treatment. Here we present the monitoring methods that are presently used ...
A new albumin-based theranostic containing gemcitabine closo-dodecaborate analogue has been developed for combining boron neutron capture therapy (BNCT) and chemotheraphy. An exo-heterocyclic amino group of gemcitabine was used to introduce closo-dodecaborate, and a 5′-hydroxy gr...
Boron (B) neutron capture therapy (BNCT) is a novel non-invasive targeted cancer therapy based on the nuclear capture reaction 10B (n, alpha) 7Li that enables the death of cancer cells without damaging neighboring normal cells. However, the development of clinically approved boron drugs remains...
Boron (B) neutron capture therapy (BNCT) is a novel non-invasive targeted cancer therapy based on the nuclear capture reaction 10B (n, alpha) 7Li that enables the death of cancer cells without damaging neighboring normal cells. However, the development of clinically approved boron drugs remains...
Boron (B) neutron capture therapy (BNCT) is a novel non-invasive targeted cancer therapy based on the nuclear capture reaction 10B (n, alpha) 7Li that enables the death of cancer cells without damaging neighboring normal cells. However, the development of clinically approved boron drugs remains...
Boron (B) neutron capture therapy (BNCT) is a novel non-invasive targeted cancer therapy based on the nuclear capture reaction 10B (n, alpha) 7Li that enables the death of cancer cells without damaging neighboring normal cells. However, the development of clinically approved boron drugs remains...